pLN343 (FuGW-H2A1p-mKate2 ) Citations (1)
Originally described in: Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.Nissim L, Wu MR, Pery E, Binder-Nissim A, Suzuki HI, Stupp D, Wehrspaun C, Tabach Y, Sharp PA, Lu TK Cell. 2017 Nov 16;171(5):1138-1150.e15. doi: 10.1016/j.cell.2017.09.049. Epub 2017 Oct 19. PubMed Journal
Articles Citing pLN343 (FuGW-H2A1p-mKate2 )
Articles |
---|
A programmable arthritis-specific receptor for guided articular cartilage regenerative medicine. Walton BL, Shattuck-Brandt R, Hamann CA, Tung VW, Colazo JM, Brand DD, Hasty KA, Duvall CL, Brunger JM. bioRxiv [Preprint]. 2024 Feb 15:2024.01.31.578281. doi: 10.1101/2024.01.31.578281. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.